Norges Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-196,393
Closed -$114M 827
2025
Q4
$114M Buy
+196,393
New +$100M 0.01% 707
2025
Q3
Sell
-176,467
Closed -$53.4M 924
2025
Q2
$53.4M Buy
176,467
+82,470
+88% +$24.6M 0.01% 925
2025
Q1
$31.1M Sell
93,997
-21,095
-18% -$6.93M ﹤0.01% 1109
2024
Q4
$35.5M Buy
115,092
+45,118
+64% +$12.7M ﹤0.01% 1090
2024
Q3
$14.8M Sell
69,974
-46,053
-40% -$11.8M ﹤0.01% 1276
2024
Q2
$32.5M Buy
116,027
+26,077
+29% +$6.21M ﹤0.01% 1082
2024
Q1
$24M Sell
89,950
-55,639
-38% -$13.1M ﹤0.01% 1208
2023
Q4
$33.7M Sell
145,589
-5,659
-4% -$990K 0.01% 1090
2023
Q3
$22.1M Buy
151,248
+15,841
+12% +$2.98M ﹤0.01% 1194
2023
Q2
$31.3M Buy
135,407
+18,816
+16% +$5.1M 0.01% 1065
2023
Q1
$28.2M Buy
116,591
+291
+0.3% +$79.3K 0.01% 1103
2022
Q4
$33.8M Hold
116,300
0.01% 1001
2022
Q3
$7.56M Buy
116,300
+6,794
+6% +$472K ﹤0.01% 1625
2022
Q2
$7.84M Hold
109,506
﹤0.01% 1652
2022
Q1
$10.7M Hold
109,506
﹤0.01% 1680
2021
Q4
$9.28M Buy
109,506
+8,500
+8% +$698K ﹤0.01% 1786
2021
Q3
$8.06M Buy
101,006
+27,347
+37% +$2.36M ﹤0.01% 1822
2021
Q2
$7.17M Sell
73,659
-32,907
-31% -$3.9M ﹤0.01% 1842
2021
Q1
$12.5M Sell
106,566
-42,922
-29% -$5M ﹤0.01% 1725
2020
Q4
$16.6M Sell
149,488
-9,994
-6% -$1.22M ﹤0.01% 1626
2020
Q3
$18.9M Buy
159,482
+17,694
+12% +$1.92M 0.01% 1458
2020
Q2
$16.1M Buy
141,788
+9,136
+7% +$898K ﹤0.01% 1564
2020
Q1
$8.86M Buy
132,652
+4,107
+3% +$342K ﹤0.01% 1667
2019
Q4
$11.7M Buy
128,545
+41,646
+48% +$4.04M ﹤0.01% 1757
2019
Q3
$7.49M Buy
86,899
+4,549
+6% +$427K ﹤0.01% 1854
2019
Q2
$8.63M Hold
82,350
﹤0.01% 1844
2019
Q1
$10.3M Hold
82,350
﹤0.01% 1789
2018
Q4
$9.28M Buy
82,350
+21,396
+35% +$3.31M ﹤0.01% 1770
2018
Q3
$13.1M Buy
+60,954
New +$15.3M ﹤0.01% 1732
2015
Q3
Sell
-10,714
Closed -$836K 2311
2015
Q2
$836K Hold
10,714
﹤0.01% 2142
2015
Q1
$727K Buy
+10,714
New +$919K ﹤0.01% 2188

Other funds holding MDGL